MedPath

nravelling the invisible infiltrating component of glioblastoma using MRI and a strong iron-like bloodpool contrast medium?

Recruiting
Conditions
Brain cancer
10029211
Registration Number
NL-OMON53350
Lead Sponsor
Radboud Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
15
Inclusion Criteria

• Aged between 18 and 75 years
• Diagnosed with suspected glioblastoma
• Eligible for neurosurgical resection and/or chemoradiation therapy.

Exclusion Criteria

• Younger than 18 years old
• Patients unfit for surgery or lesions unsuitable for neurosurgical treatment

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Is it feasible to perform a study of USPIO neuro-imaging in healthy<br /><br>participants (n=6)?</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Can we robustly perform MR imaging of glioblastoma by use of a new Off Road<br /><br>multi-sequence protocol (i.e., T1w, T2w, FLAIR, DWI/DTI, SWI, T1w- and T2*w<br /><br>post-USPIO images) in 15 GBM patients to visualize tumor infiltration?<br /><br><br /><br>What is the diagostic accuracy of the Off Road imaging protocol to predict<br /><br>tumor recurrence?</p><br>
© Copyright 2025. All Rights Reserved by MedPath